Chronic Lung Diseases Completed Phase 2 / 3 Trials for Imatinib (DB00619)

Also known as: Lung Disease / Lung Diseases / Chronic Lung Disease / Calcification of lung / Disorder lung / Lung disorder / Lung disorder (NOS) / Lung disorder NOS / Pulmonary disorder / Disorder pulmonary / Pneumopathy

IndicationStatusPhase
DBCOND0044039 (Chronic Lung Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00131274Gleevec Idiopathic Pulmonary Fibrosis (IPF) StudyEducational/Counseling/Training